sitagliptin glp 1 agonist Frontiers GLP-1 Agonists - What is
Description
Halloum W, Dughem YA, Beier D, Pellesi L
Four additional states have coverage in place but only for older drugs that are not GLP-1s
These novel treatments aim to not only help patients shed excess weight but also improve metabolic health, reducing the risk of obesity-related conditions like diabetes and cardiovascular disease
The glucagon-like peptide 1 (GLP-1) analogue exendin-4 reduces alcohol intake and attenuates cue-induced reinstatement of alcohol seeking in rats
GLP-1RAs act on several of these mechanisms
10.15605/jafes.037.02.14 42
